| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ZIC1 mRNA | affects expression | 16483693
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of ZIC1 mRNA | decreases expression | 20106945
|
| D003520 |
Cyclophosphamide |
ZIC1 protein affects the susceptibility to Cyclophosphamide | affects response to substance | 16217747
|
| C014347 |
decitabine |
decitabine affects the methylation of ZIC1 promoter | affects methylation | 17936758
|
| C014347 |
decitabine |
decitabine results in increased expression of ZIC1 mRNA | increases expression | 17936758
|
| C014347 |
decitabine |
trichostatin A promotes the reaction [decitabine results in increased expression of ZIC1 mRNA] | increases expression|increases reaction | 17936758
|
| D004041 |
Dietary Fats |
Dietary Fats results in increased expression of ZIC1 mRNA | increases expression | 18042831
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZIC1 mRNA | affects cotreatment|increases expression | 17942748
|
| C041786 |
palm oil |
palm oil results in increased expression of ZIC1 mRNA | increases expression | 18042831
|
| C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of ZIC1 mRNA | affects expression | 17440010
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ZIC1 mRNA | increases expression | 19684285
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZIC1 mRNA | affects cotreatment|increases expression | 17942748
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ZIC1 mRNA | increases expression | 16267337
|
| C012589 |
trichostatin A |
trichostatin A promotes the reaction [decitabine results in increased expression of ZIC1 mRNA] | increases expression|increases reaction | 17936758
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.08 | 15322242 11752688 14514962 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.80 | 18287403 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.21 | 17505938 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.30 | 20464547 20127859 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.30 | 14692618 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.74 | 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.29 | 19183758 |
| MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
18.38 | 15014928 |
| MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
18.38 | 15238619 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
18.38 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.76 | 15885639 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.21 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.39 | 17474063 20146248 |
| MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.39 | 16978400 18234424 18323546 17388661 15093573 11325840 15136595 17020986 12006526 |
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.39 | 18320071 19208741 |
| MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.39 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.39 | 20435547 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
2.62 | 19701751 |
| MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.13 | 16152834 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.61 | 16201981 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.82 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.82 | 19215824 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 16120746 18850075 18670907 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.00 | 17333356 17110522 16105132 15861022 17681005 11677210 16919318 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.16 | 12621046 15340226 15668235 16354765 8697196 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.36 | 17616700 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 14669216 17141729 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
| MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.25 | 15643279 18093676 18710439 12161096 18433785 10498854 12913760 15276878 17979934 10700343 18483878 18372110 16989017 12388444 18295254 16614059 16413132 17010015 16651033 11948286 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.21 | 15331540 11751995 10990075 |
| MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.26 | 18772604 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.57 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
| MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.57 | 18367378 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.55 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.17 | 18230668 16714409 15322242 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.38 | 12538720 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
14.93 | 19294695 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
14.93 | 19294695 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 9294722 10568697 |
| MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.43 | 11006010 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.04 | 16530937 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.14 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
8.30 | 18296743 19551842 17967931 19004024 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
8.30 | 15345470 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Dietary Fats |
9.35 | 18296743 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.35 | 20067830 |
| MESH:D005909 |
Glioblastoma |
|
trichostatin A |
3.94 | 18801729 |
| MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.75 | 11389073 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
| MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.25 | 15172196 16376943 11014644 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.60 | 19215824 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.72 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.72 | 10048152 11294989 |
| MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.51 | 11918545 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
| MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.80 | 14986274 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 12621046 16120746 15340226 |
| MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.01 | 17440010 |
| MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
3.93 | 17606976 16135485 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 18606429 8697196 16354765 15340226 16959395 |
| MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.76 | 21332399 |
| MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.80 | 21332399 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.96 | 18850075 18670907 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.02 | 16945680 16569931 |
| MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.60 | 16076520 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.65 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
11.97 | 7193160 16517039 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
11.97 | 17581917 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.97 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.19 | 20412841 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.19 | 12878042 12200463 |
| MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.21 | 11836018 18457598 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.51 | 16580747 |
| MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.95 | 10602166 |
| MESH:D007938 |
Leukemia |
|
decitabine |
6.95 | 19235587 18980019 |
| MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.56 | 17802794 17658394 17008537 18587576 17296974 18172266 |
| MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.21 | 10373061 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.17 | 17236224 19117987 18454857 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.36 | 18460780 18206229 17679729 18704418 19387464 19010910 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.36 | 18206229 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.73 | 18055864 |
| MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.20 | 11830472 10052129 |
| MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.96 | 18296743 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.52 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.52 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.20 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.22 | 20464547 18569708 17053015 18816296 20135361 6695378 18520028 20064080 20869020 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.22 | 11884234 19555203 |
| MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
8.27 | 12854902 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
8.27 | 19470736 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.78 | 16675587 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.31 | 11911406 |
| MESH:D008545 |
Melanoma |
|
decitabine |
3.81 | 16505122 17785578 |
| MESH:D008545 |
Melanoma |
|
trichostatin A |
3.81 | 16505122 |
| MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
5.02 | 16388313 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.32 | 16381670 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
8.06 | 18172295 |
| MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
8.06 | 18172295 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.47 | 18608210 19157545 19010910 16882708 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.85 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
8.85 | 18854779 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
8.85 | 19116145 17925555 19470736 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.41 | 14600291 |
| MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.72 | 15176712 8761367 16115947 |
| MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.13 | 8761367 12837982 |
| MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.51 | 8291058 |
| MESH:D009765 |
Obesity |
|
Dietary Fats |
2.32 | 19632207 18457598 18674790 21332399 20132043 11836018 17217161 16723640 20518802 |
| MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.95 | 16517039 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
5.42 | 19331143 19259094 |
| MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
5.42 | 19331143 |
| MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.76 | 18093676 12161096 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
9.18 | 11332152 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
9.18 | 19294695 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
9.18 | 19294695 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.87 | 11578682 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
| MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.89 | 21297632 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.43 | 11896295 11399792 11118676 11222880 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
13.16 | 17616702 |
| MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
13.16 | 17616702 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.71 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.71 | 17136230 |
| MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.71 | 19789329 18798265 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.55 | 15861022 16919318 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.34 | 16636934 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.59 | 19155313 |
| MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
5.01 | 16636934 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.72 | 10029692 19755658 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.72 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.21 | 16709447 |
| OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.75 | 16517039 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.49 | 2093021 20155912 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.49 | 19037991 |
| MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.29 | 12837982 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.80 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.30 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.46 | 17967635 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.79 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
8.79 | 14692829 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.79 | 19087683 17616700 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.50 | 14692618 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.18 | 17785578 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.71 | 15869587 14671159 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
| MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.89 | 16723640 |